Novo Nordisk Investigational Site
Bratislava, 811 05, Slovakia
NCT Number: NCT01516242
This study is conducted in Europe. The aim of the study is to monitor patients changing therapy from syringe to insulin delivery system as prescribed by the treating physician in Slovakia.
Looking for future studies?
Notify MeAll sexes
Observational
Bratislava, 811 05, Slovakia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Collection of data about patients with type 1 diabetes or type 2 diabetes treated with insulin changing their insulin administration from syringe to a insulin delivery system based on completion of questionaire
Novo Nordisk A/S
Industry
Monitoring of Expected Parameters of the Application Technique and Safety of the Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00773279
Autoimmune Diseases, Delivery Systems
Burlingame, California, United States
View Trial DetailsNCT01680328
Autoimmune Diseases, Delivery Systems
Neuss, Germany
View Trial DetailsNCT00871416
Autoimmune Diseases, Delivery Systems
Aarhus, Denmark
View Trial DetailsNCT00343343
Autoimmune Diseases, Delivery Systems
Aalborg, Denmark
View Trial Details